In addition, the promoter methylation of CYFIP2 in tumor tissues of TCGA-LUAD was significantly lower than that of normal tissues adjacent to the cancer regardless of different clinical stages, N stages, gender, age and smoking status (Fig. 5D–H). This evidence concerns the gene CYFIP2 and cancer.